Research - News
One participant said, “It seems like we’ve done 10 years of work in seven months!”
The study suggests that depressive symptoms are a nontraditional risk factor for stroke, something medical professionals need to take into account when talking with their patients.
High-profile speakers show the “critical role that UAB is playing in the effort to combat this pandemic.”
This study used powerful genomic tools and supercomputers to analyze massive amounts of genetic data and identify individual strains within single species of the gut microbiome present during an infant’s first 6 years of life.
A UAB expert investigates Zoom’s security code validation approach for the online safety of users.
The grant will help UAB researchers evaluate the impact of mild traumatic brain injury on teen driving and develop guidelines on when teens can safely get back behind the wheel.
The review of COVID-19 positive case rates and state-wide stay-at-home orders suggests that stay-at-home orders helped reduce transmission of the SARS-CoV-2 virus.
Layers of tannic acid and another biopolymer delay allograft and autoimmune-mediated rejection in mouse models of Type 1 diabetes.
The loss of rural hospitals has been felt most keenly in Southern regions of the United States, from Florida to Texas.
A study conducted by UAB investigators has outlined that Black individuals are disproportionately affected by COVID-19, and there are key geographic differences in health determinants in the United States.
A national report co-written by a UAB dentist found that dentists who were assumed to be at increased risk of COVID exposure had a less than 1 percent infection rate of COVID-19.
A monoclonal antibody is being developed by Aridis Pharmaceuticals as an inhaled, self-administered treatment for non-hospitalized patients who are suffering from mild to moderate COVID-19.
New recommendations for treatment and prevention of HIV infection in adults will help guide physicians and patients in HIV therapies and treatment regimens.
UAB will build an autonomous vehicle mobility facility that works in collaboration with its Engineering and Innovative Technology Development research group.
Integration of the telehealth platform in a multiphase optimization strategy evaluation will allow researchers to develop behavioral health approaches that are more realistic and tailored to the individual’s goals and health needs.
UAB’s new cystic kidney disease core center will spearhead a multidisciplinary approach to finding treatments for this devastating disease
The vaccine candidate Altimmune’s AdCOVID potently stimulated neutralizing antibody and T cell responses, as well as mucosal immunity in the respiratory tract.
Precision disease modeling involves creation of patient-specific disease models that mimic the molecular character of a condition present in a patient, enabling more precise diagnoses and treatments.
UAB researchers will use existing knowledge and research to address urgent needs for rapid SARS-CoV-2 testing among underserved populations.
The virus responsible for COVID-19 seems to have an affinity for the heart, leading to concerns for an increase in heart issues among young athletes.
This avenue of basic research will aid understanding of neurodevelopmental disorders in humans.
UAB stands 22nd in the nation in research funding from the National Institutes of Health.
A $1.95 million grant will allow UAB researchers to develop an online tool to help educate children on firearms safety.
The exosomes were secreted by cardiac cells derived from human induced pluripotent stem cells. These non-living exosomes may be an easier form of regenerative treatment than living cells.
The UAB Nathan Shock Center received a $4.5 million grant renewal from the National Institute on Aging to further engage in cutting-edge research focused on comparative bioenergetics and aging.
American Heart Association special report highlights trends in awareness among women in the United States regarding heart disease.
These molecular insights may foster effective therapies using existing drugs for patients with COVID-19.
The grant is designed to bring disparate investigators together, to foster communication and collaboration among researchers.
This study of ischemic stroke patients is the first to associate the neutrophil-lymphocyte ratio in patients with COVID-19 and ischemic stroke and stroke severity.
Researchers at UAB continue leading the way in finding the best personal protective equipment for use.